Fmoc-(RS)-3-amino-3-(3-nitrophenyl)-propionic acid, 97%, 25g

4-Bromo-3-methyl-pyridine-2-carbonitrile, 98+%, 1g

2-(ALLYL(BENZYL)AMINO)ACETONITRILE, 95.0%, 250mg

N,N'-Bis[4-di(m-tolyl)aminophenyl]-N,N'-diphenylbenzidine, >98.0%(HPLC), 5g

2-(2,5-Dimethoxybenzoyl)-4-methylpyridine, 97.0%, 1g

1-cyclohexyl-2,3-dihydro-1H-imidazole-2-thione, 98%, 1g

Decahydroisoquinoline (cis- and trans- mixture, predominantly cis-isomer)>98.0%(GC)25mL

1-N-Boc-4-N-Fmoc-Aminopiperidine-4-carboxylic acid, 95.0%, 1g

3,5-Dichloro-4-(trifluoromethyl)pyridin-2-ol, 95.0%, 5g

2-Amino-5-[2-(trifluoromethyl)phenyl]-1,3,4-thiadiazole, 98.0%, 1g

4-Dimethylaminobutan-1-ol, 97.0%, 25g

5-Ethynyl-3-methyl-2-pyridinecarbonitrile, 100mg

6-Bromo-1-methylisoquinoline, 97%, 100mg